BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 28240787)

  • 1. Newly diagnosed immune thrombocytopenia adults: Clinical epidemiology, exposure to treatments, and evolution. Results of the CARMEN multicenter prospective cohort.
    Moulis G; Germain J; Comont T; Brun N; Dingremont C; Castel B; Arista S; Sailler L; Lapeyre-Mestre M; Beyne-Rauzy O; Godeau B; Adoue D;
    Am J Hematol; 2017 Jun; 92(6):493-500. PubMed ID: 28240787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics and management of primary and other immune thrombocytopenias: Spanish registry study.
    Palau J; Sancho E; Herrera M; Sánchez S; Mingot ME; Upegui RI; Rodríguez Salazar MJ; de la Cruz F; Fernández MC; González López TJ; Hernández JJ; Ríos E; López-Fernández MF; García M; Hernández JÁ; Sanz MA
    Hematology; 2017 Sep; 22(8):484-492. PubMed ID: 28415913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune thrombocytopenia in adults: a prospective cohort study of clinical features and predictors of outcome.
    Grimaldi-Bensouda L; Nordon C; Michel M; Viallard JF; Adoue D; Magy-Bertrand N; Durand JM; Quittet P; Fain O; Bonnotte B; Morin AS; Morel N; Costedoat-Chalumeau N; Pan-Petesch B; Khellaf M; Perlat A; Sacre K; Lefrere F; Abenhaim L; Godeau B;
    Haematologica; 2016 Sep; 101(9):1039-45. PubMed ID: 27229715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary immune thrombocytopenia in very elderly patients: particularities in presentation and management: results from the prospective CARMEN-France Registry.
    Sokal A; de Nadaï T; Maquet J; Comont T; Limal N; Michel M; Beyne-Rauzy O; Godeau B; Adoue D; Mahévas M; Moulis G;
    Br J Haematol; 2022 Mar; 196(5):1262-1270. PubMed ID: 34738634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for bleeding, including platelet count threshold, in newly diagnosed immune thrombocytopenia adults.
    Piel-Julian ML; Mahévas M; Germain J; Languille L; Comont T; Lapeyre-Mestre M; Payrastre B; Beyne-Rauzy O; Michel M; Godeau B; Adoue D; Moulis G;
    J Thromb Haemost; 2018 Sep; 16(9):1830-1842. PubMed ID: 29978544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacoepidemiology of Immune Thrombocytopenia: protocols of FAITH and CARMEN studies.
    Moulis G; Sailler L; Adoue D; Lapeyre-Mestre M
    Therapie; 2014; 69(5):437-48. PubMed ID: 25285364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of an algorithm identifying incident primary immune thrombocytopenia in the French national health insurance database.
    Mezaache S; Derumeaux H; Ferraro P; Capdepon P; Steinbach JC; Abballe X; Palas D; Saichi N; Desboeuf K; Lapeyre-Mestre M; Sailler L; Moulis G
    Eur J Haematol; 2017 Oct; 99(4):344-349. PubMed ID: 28692146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France.
    Moulis G; Palmaro A; Montastruc JL; Godeau B; Lapeyre-Mestre M; Sailler L
    Blood; 2014 Nov; 124(22):3308-15. PubMed ID: 25305203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epidemiology, disease presentation and course of idiopathic thrombocytopenic purpura in Danish children from 1998-2000].
    Kjaersgaard M; Edslev PW; Rosthøj S
    Ugeskr Laeger; 2008 May; 170(22):1922-6. PubMed ID: 18513475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Management of autoimmune thrombocytopenic purpura: a prospective study of 147 children from the regional network RHémaP].
    Le Meignen M; Mossler P; Mates M; Mathey C; Hass A; Monpoux F; Faverge B; Fortier G; Nguyen J; Belahbib L; Coache C; Chamoulli JM; Moulène E; Sirvent N; Michel G; Chambost H
    Arch Pediatr; 2008 Sep; 15(9):1398-406. PubMed ID: 18676127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Epidemiology, Treatment Outcome and Mortality Rate of Newly Diagnosed Immune Thrombocytopenia in Adult Multicentre Study in Malaysia.
    Hamzah R; Yusof N; Tumian NR; Abdul Aziz S; Mohammad Basri NS; Leong TS; Ho KW; Selvaratnam V; Tan SM; Muhamad Jamil SA
    J Blood Med; 2022; 13():337-349. PubMed ID: 35761846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Idiopathic thrombocytopenic purpura in children].
    Gebauer E; Vijatov G
    Med Pregl; 1998; 51(3-4):127-34. PubMed ID: 9611955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of remission in children with newly diagnosed immune thrombocytopenia: Data from the Intercontinental Cooperative ITP Study Group Registry II participants.
    Bennett CM; Neunert C; Grace RF; Buchanan G; Imbach P; Vesely SK; Kuhne T
    Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28792679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epidemiology and pharmacoepidemiology of immune thrombocytopenia].
    Moulis G; Lapeyre-Mestre M; Adoue D; Sailler L
    Rev Med Interne; 2017 Jul; 38(7):444-449. PubMed ID: 28131440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adolescents and young adults with newly diagnosed primary immune thrombocytopenia.
    Schifferli A; Moulis G; Godeau B; Leblanc T; Aladjidi N; Michel M; Leverger G; Elalfy M; Grainger J; Chitlur M; Heiri A; Holzhauer S; Le Gavrian G; Imbach P; Kühne T
    Haematologica; 2023 Oct; 108(10):2783-2793. PubMed ID: 37051753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinical prediction score for transient versus persistent childhood immune thrombocytopenia.
    Schmidt DE; Wendtland Edslev P; Heitink-Pollé KMJ; Mertens B; Bruin MCA; Kapur R; Vidarsson G; van der Schoot CE; Porcelijn L; van der Bom JG; Rosthøj S; de Haas M
    J Thromb Haemost; 2021 Jan; 19(1):121-130. PubMed ID: 33058474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune thrombocytopenic purpura in adults in the last 10 years: single-centre experience.
    Pavkovic M; Trpkovska-Terzieva S; Sotirova T; Latifi A; Cevreska L; Stojanovic A
    Prilozi; 2012; 33(1):121-33. PubMed ID: 22952099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Childhood immune thrombocytopenia: A nationwide cohort study on condition management and outcomes.
    Grimaldi-Bensouda L; Nordon C; Leblanc T; Abenhaim L; Allali S; Armari-Alla C; Berger C; Courcoux MF; Fouyssac F; Guillaumat C; Guitton C; Le Moine P; Mazingue F; Pondarré C; Thomas C; Pasquet M; Perel Y; Leverger G; Aladjidi N
    Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 27905681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the impact and burden of illness of adult chronic ITP in the US.
    Saleh MN; Fisher M; Grotzinger KM
    Curr Med Res Opin; 2009 Dec; 25(12):2961-9. PubMed ID: 19835465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama.
    Watts RG
    Clin Pediatr (Phila); 2004 Oct; 43(8):691-702. PubMed ID: 15494875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.